ConjuChem
Canadian biotechnology company
From Wikipedia, the free encyclopedia
ConjuChem Biotechnologies Inc. is a medical biotechnology company located in Montreal, Quebec, Canada[1] which is credited with inventing the experimental peptide hormone CJC-1295.[2][3]
Company typePublic (TSX has Delisted this Stock)
IndustryBiotechnology
Key people
Mark Perrin| Company type | Public (TSX has Delisted this Stock) |
|---|---|
| Industry | Biotechnology |
| Headquarters | , |
Key people | Mark Perrin |
| Products | Drug Affinity Construct (DAC) and Preformed Conjugate-Drug Affinity Construct (PC-DAC) |
Number of employees | 44[citation needed][needs update] |
| Website | www.conjuchem.com |
It employs 45 people, 90% of whom are in research and development.[citation needed][needs update]
.svg){kind=small}
